company background image
SVS logo

Svas Biosana BIT:SVS Stock Report

Last Price

€8.20

Market Cap

€43.0m

7D

4.9%

1Y

5.1%

Updated

29 May, 2025

Data

Company Financials +

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Svas Biosana S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Svas Biosana
Historical stock prices
Current Share Price€8.20
52 Week High€8.55
52 Week Low€6.48
Beta0.91
1 Month Change7.33%
3 Month Change6.49%
1 Year Change5.13%
3 Year Change-31.21%
5 Year Changen/a
Change since IPO-43.41%

Recent News & Updates

Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

May 16
Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

Recent updates

Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

May 16
Svas Biosana's (BIT:SVS) Profits May Not Reveal Underlying Issues

Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

May 10
Svas Biosana's (BIT:SVS) Earnings Are Weaker Than They Seem

The Returns At Svas Biosana (BIT:SVS) Aren't Growing

Dec 09
The Returns At Svas Biosana (BIT:SVS) Aren't Growing

We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Oct 06
We Think You Should Be Aware Of Some Concerning Factors In Svas Biosana's (BIT:SVS) Earnings

Shareholder Returns

SVSIT Medical EquipmentIT Market
7D4.9%-1.6%-0.7%
1Y5.1%-7.2%16.9%

Return vs Industry: SVS exceeded the Italian Medical Equipment industry which returned -7.2% over the past year.

Return vs Market: SVS underperformed the Italian Market which returned 16.9% over the past year.

Price Volatility

Is SVS's price volatile compared to industry and market?
SVS volatility
SVS Average Weekly Movement5.7%
Medical Equipment Industry Average Movement5.7%
Market Average Movement5.5%
10% most volatile stocks in IT Market8.7%
10% least volatile stocks in IT Market3.4%

Stable Share Price: SVS has not had significant price volatility in the past 3 months compared to the Italian market.

Volatility Over Time: SVS's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1972327Umberto Perillosvas.it

SVAS Biosana S.p.A. engages in the production and marketing of medical devices worldwide. The company offers incontinence aids, traditional dressings, and personal care products for use in incontinence devices, dressings, and personal care product applications. It also offers operating packs, medical devices, infusion and aspiration, linen, advanced dressings, and lubricating gels that are used in haemodynamic, heart surgery, anaesthesia, and critical care applications.

Svas Biosana S.p.A. Fundamentals Summary

How do Svas Biosana's earnings and revenue compare to its market cap?
SVS fundamental statistics
Market cap€43.04m
Earnings (TTM)€5.87m
Revenue (TTM)€122.29m
7.4x
P/E Ratio
0.4x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SVS income statement (TTM)
Revenue€122.29m
Cost of Revenue€87.92m
Gross Profit€34.37m
Other Expenses€28.49m
Earnings€5.87m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.11
Gross Margin28.10%
Net Profit Margin4.80%
Debt/Equity Ratio105.0%

How did SVS perform over the long term?

See historical performance and comparison

Dividends

3.0%
Current Dividend Yield
23%
Payout Ratio

Does SVS pay a reliable dividends?

See SVS dividend history and benchmarks
When do you need to buy SVS by to receive an upcoming dividend?
Svas Biosana dividend dates
Ex Dividend DateJun 09 2025
Dividend Pay DateJun 11 2025
Days until Ex dividend10 days
Days until Dividend pay date12 days

Does SVS pay a reliable dividends?

See SVS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/29 21:31
End of Day Share Price 2025/05/29 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Svas Biosana S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simone MieliTPICAP Midcap
Mathias PaladinoTPICAP Midcap